Annual FCF
-$91.47 M
+$7.54 M+7.62%
December 31, 2023
Summary
- As of February 12, 2025, FULC annual free cash flow is -$91.47 million, with the most recent change of +$7.54 million (+7.62%) on December 31, 2023.
- During the last 3 years, FULC annual FCF has fallen by -$36.48 million (-66.32%).
- FULC annual FCF is now -316.13% below its all-time high of -$21.98 million, reached on December 31, 2017.
Performance
FULC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$19.09 M
-$77.99 M-132.41%
September 30, 2024
Summary
- As of February 12, 2025, FULC quarterly free cash flow is -$19.09 million, with the most recent change of -$77.99 million (-132.41%) on September 30, 2024.
- Over the past year, FULC quarterly FCF has increased by +$4.14 million (+17.84%).
- FULC quarterly FCF is now -132.41% below its all-time high of $58.90 million, reached on June 30, 2024.
Performance
FULC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.74 M
+$3.88 M+30.75%
September 30, 2024
Summary
- As of February 12, 2025, FULC TTM free cash flow is -$8.74 million, with the most recent change of +$3.88 million (+30.75%) on September 30, 2024.
- Over the past year, FULC TTM FCF has increased by +$82.73 million (+90.45%).
- FULC TTM FCF is now -17.86% below its all-time high of -$7.42 million, reached on March 31, 2018.
Performance
FULC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FULC Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.6% | +17.8% | +90.5% |
| 3 y3 years | -66.3% | +17.8% | +90.5% |
| 5 y5 years | -190.0% | +17.8% | +90.5% |
FULC Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | +7.6% | -132.4% | +33.4% | at high | +91.4% |
| 5 y | 5-year | -126.8% | +7.6% | -132.4% | +33.4% | at high | +91.4% |
| alltime | all time | -316.1% | +7.6% | -132.4% | +33.4% | -17.9% | +91.4% |
Fulcrum Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.09 M(-132.4%) | -$8.74 M(-30.7%) |
| Jun 2024 | - | $58.90 M(-332.7%) | -$12.62 M(-86.4%) |
| Mar 2024 | - | -$25.31 M(+8.9%) | -$92.50 M(+1.1%) |
| Dec 2023 | -$91.47 M(-7.6%) | -$23.23 M(+1.1%) | -$91.47 M(+3.9%) |
| Sep 2023 | - | -$22.97 M(+9.5%) | -$88.05 M(-5.6%) |
| Jun 2023 | - | -$20.98 M(-13.6%) | -$93.24 M(-7.6%) |
| Mar 2023 | - | -$24.29 M(+22.6%) | -$100.95 M(+2.0%) |
| Dec 2022 | -$99.01 M(+23.5%) | -$19.81 M(-29.7%) | -$99.01 M(-2.5%) |
| Sep 2022 | - | -$28.16 M(-1.8%) | -$101.58 M(+5.4%) |
| Jun 2022 | - | -$28.68 M(+28.3%) | -$96.35 M(+12.0%) |
| Mar 2022 | - | -$22.35 M(-0.1%) | -$86.06 M(+7.3%) |
| Dec 2021 | -$80.19 M | -$22.38 M(-2.5%) | -$80.19 M(+2.7%) |
| Sep 2021 | - | -$22.94 M(+24.8%) | -$78.11 M(+30.7%) |
| Jun 2021 | - | -$18.39 M(+11.5%) | -$59.77 M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$16.49 M(-18.8%) | -$55.71 M(+1.3%) |
| Dec 2020 | -$55.00 M(+36.3%) | -$20.30 M(+341.5%) | -$55.00 M(+39.9%) |
| Sep 2020 | - | -$4.60 M(-67.9%) | -$39.30 M(-18.0%) |
| Jun 2020 | - | -$14.33 M(-9.1%) | -$47.94 M(+4.4%) |
| Mar 2020 | - | -$15.77 M(+242.6%) | -$45.90 M(+13.8%) |
| Dec 2019 | -$40.34 M(+27.9%) | -$4.60 M(-65.2%) | -$40.34 M(-11.5%) |
| Sep 2019 | - | -$13.23 M(+7.6%) | -$45.60 M(+21.9%) |
| Jun 2019 | - | -$12.29 M(+20.5%) | -$37.42 M(+9.0%) |
| Mar 2019 | - | -$10.21 M(+3.4%) | -$34.34 M(+8.9%) |
| Dec 2018 | -$31.54 M(+43.5%) | -$9.87 M(+95.6%) | -$31.54 M(+45.5%) |
| Sep 2018 | - | -$5.05 M(-45.2%) | -$21.67 M(+30.3%) |
| Jun 2018 | - | -$9.21 M(+24.2%) | -$16.63 M(+124.2%) |
| Mar 2018 | - | -$7.42 M | -$7.42 M |
| Dec 2017 | -$21.98 M | - | - |
FAQ
- What is Fulcrum Therapeutics annual free cash flow?
- What is the all time high annual FCF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual FCF year-on-year change?
- What is Fulcrum Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly FCF year-on-year change?
- What is Fulcrum Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM FCF year-on-year change?
What is Fulcrum Therapeutics annual free cash flow?
The current annual FCF of FULC is -$91.47 M
What is the all time high annual FCF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual free cash flow is -$21.98 M
What is Fulcrum Therapeutics annual FCF year-on-year change?
Over the past year, FULC annual free cash flow has changed by +$7.54 M (+7.62%)
What is Fulcrum Therapeutics quarterly free cash flow?
The current quarterly FCF of FULC is -$19.09 M
What is the all time high quarterly FCF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly free cash flow is $58.90 M
What is Fulcrum Therapeutics quarterly FCF year-on-year change?
Over the past year, FULC quarterly free cash flow has changed by +$4.14 M (+17.84%)
What is Fulcrum Therapeutics TTM free cash flow?
The current TTM FCF of FULC is -$8.74 M
What is the all time high TTM FCF for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM free cash flow is -$7.42 M
What is Fulcrum Therapeutics TTM FCF year-on-year change?
Over the past year, FULC TTM free cash flow has changed by +$82.73 M (+90.45%)